Doctors Criticize Health Insurers’ Patient Data Evaluation
- Several health insurers are initiating programs to proactively warn policyholders about potential health risks, ranging from cancer to infectious diseases.
- Though, questions remain about the specifics of these warning systems.
- Some insurers are developing proprietary algorithms to analyse patient data.
Health Insurers Using Data to Warn Patients, Sparking Debate
Table of Contents
- Health Insurers Using Data to Warn Patients, Sparking Debate
- Health Insurers Using Data to Warn patients: Your Questions Answered
- What are health insurers doing with patient data?
- how are insurers analyzing this data?
- Why are some insurers hesitant about using AI?
- What is the viewpoint on using AI in diagnostics?
- What are the potential risks of these data-driven programs?
- What about data privacy?
- What specific health risks are targeted?
Several health insurers are initiating programs to proactively warn policyholders about potential health risks, ranging from cancer to infectious diseases. Two insurers plan to alert individuals to the risks of breast and colon cancer. Another aims to identify previously undiagnosed care needs,while yet another will focus on stroke risk. Six insurers intend to promote vaccinations against pneumococcal disease, herpes zoster, and human papillomavirus (HPV). Barmer, in response to an inquiry, stated its specific intention to encourage young people to complete HPV vaccinations.
Though, questions remain about the specifics of these warning systems. The quality of data, the functionality of the algorithms used, and their overall reliability are all areas of uncertainty. Barmer acknowledged receiving billing data with delays of up to nine months.
Data Analysis and Artificial Intelligence
Some insurers are developing proprietary algorithms to analyse patient data. The costs associated with these algorithms and whether they will be made public remain unclear for AOK, Techniker Krankenkasse (TK), and Barmer. Barmer has stated it will not use artificial intelligence (AI) in its analysis,potentially because AI-driven results can be difficult to explain – a crucial factor when doctors need to understand diagnoses for serious illnesses. In contrast, TK head Jens Baas expressed support for AI in diagnostics.Speaking at an AI festival in the fall of 2024, Baas said, “It will soon be an art defect to make a diagnosis without AI.”
Regardless of whether AI is used, differences exist in how health insurers approach preventative care. The AOK Federal Association noted that identifying serious health risks through algorithms is more complex than simply recognizing a lack of vaccination.
Data Protection Concerns
The Federal Data Protection Officer emphasized the need for insured individuals to be properly informed about data evaluation practices. While insurers are permitted to evaluate data without explicit consent, they must notify policyholders four weeks in advance. The method for providing this notification remains undefined.
Christof Stein, a spokesman for the federal Data Protection Officer, stressed that simply posting data on the health insurance company’s website is insufficient. “The insured actually have to be reached,” Stein said, noting that individuals have the right to object to data-based evaluations. Effective dialog, such as letters or emails, is necessary to ensure individuals are aware of their rights.
Uneven Access to Data-Driven healthcare
Access to these early warning systems depends on the insurer a person is insured by. Some insurers offer cancer risk warnings, while others do not. This means that legally insured individuals do not benefit equally from data evaluations. The Federal Ministry of Health confirmed that the use of data processing options is at the discretion of individual health insurance companies, determining whether insured individuals can benefit from such programs.
Health Insurers Using Data to Warn patients: Your Questions Answered
Are health insurers using your data to predict your health risks? Here’s what you need to know about this emerging trend in healthcare and the concerns it raises, all based on the information available.
What are health insurers doing with patient data?
Several health insurers are launching programs to proactively alert policyholders about potential health risks. These programs cover a range of conditions:
Cancer: Some insurers plan to warn about breast and colon cancer risks.
Undiagnosed Needs: One insurer aims to identify previously undiagnosed care needs.
Stroke Risk: Another will focus on stroke risk.
Vaccinations: Six insurers intend to promote vaccinations against pneumococcal disease, herpes zoster, and HPV.
how are insurers analyzing this data?
Some insurers are developing their own algorithms, using patient data (presumably including billing information and other relevant records), to analyze patient data. However, the specifics of exactly how these algorithms work, as well as their associated costs, remain unclear for some insurers like AOK, Techniker Krankenkasse (TK), and Barmer. Barmer has stated that it will not use artificial intelligence (AI) in its analysis.
Why are some insurers hesitant about using AI?
Barmer’s decision not to use AI could be related to the potential difficulty in explaining AI-driven results. This is vital because doctors need to understand the basis for diagnoses, especially for serious illnesses.
What is the viewpoint on using AI in diagnostics?
In contrast to Barmer, TK head Jens Baas has expressed support for AI in diagnostics. At an AI festival in the fall of 2024, Baas stated that “It will soon be an art defect to make a diagnosis without AI.” This suggests differing views on the role and value of AI in this area.
What are the potential risks of these data-driven programs?
Data Quality Concerns
One concern is the quality of the data used. Barmer has acknowledged delays of up to nine months in receiving billing data.
Data Protection
The Federal Data Protection Officer has emphasized the importance of informing insured individuals about data evaluation practices. While health insurers are permitted to evaluate data without explicit consent, they must notify policyholders four weeks in advance. Though, the method for providing this notification is undefined.
How will I be notified if my data is being used?
Christof Stein, a spokesman for the Federal Data Protection Officer, notes that simply posting data on a website is insufficient. The insured need to be actively reached through effective dialog, such as letters or emails, to ensure they are aware of their rights. Individuals also have the right to object to data-based evaluations.
Uneven Access
Access to these early warning systems depends on the insurance company a person is insured by. Some insurers offer cancer risk warnings, while others do not. This means that not everyone benefits equally from data evaluations. The federal Ministry of Health confirms that the use of data processing options is at the discretion of individual health insurance companies.
What about data privacy?
Data privacy is a significant concern.Here’s what you should be mindful of:
Notification: You must be informed about how your data is used.
Consent: Explicit consent isn’t always required, but you must be notified.
* Objection: You have the right to object to data-based evaluations.
What specific health risks are targeted?
Here is a breakdown of the health risks being targeted by the insurers, based on the provided information:
| health Risk | Examples | Notes |
|---|---|---|
| Cancer | Breast and colon cancer | Some insurers are launching programs |
| Undiagnosed Care Needs | unspecified | One insurer is aiming to identify them. |
| Stroke | stroke risk | One insurer is focusing on this. |
| Infectious Diseases | Pneumococcal disease, herpes zoster, HPV | Programs promoting vaccinations |